# Evaluating Tumor Pseudoprogression With FLT-PET and MRI

> **NCT01105988** · EARLY_PHASE1 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 2 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **OTHER:** Radiologic exams

## Key facts

- **NCT ID:** NCT01105988
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Funding ended
- **Last updated:** 2012-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01105988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01105988, "Evaluating Tumor Pseudoprogression With FLT-PET and MRI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01105988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*